IPO Pipeline Overview - As of February 8, there are 318 companies in the IPO pipeline, with 20 on the Shanghai Main Board, 41 on the Sci-Tech Innovation Board, 18 on the Shenzhen Main Board, 37 on the Growth Enterprise Market, and 202 on the Beijing Stock Exchange [2] - The total number of companies at various stages includes 8 accepted, 227 under inquiry, 16 approved, 46 suspended, and 21 submitted for registration [3] Newly Listed Companies - Two companies were newly listed between February 2 and February 8: - Shimen Supply Chain Management Co., Ltd. listed on February 3 on the Shenzhen Main Board with stock code 001220, closing at 57.73 yuan per share, a rise of 106.18%, with a trading volume of 1.093 billion yuan and a turnover rate of 76.68% [5] - Shenzhen Beixin Life Technology Co., Ltd. listed on February 5 on the Sci-Tech Innovation Board with stock code 688712, closing at 49.64 yuan per share, a rise of 183.33%, with a trading volume of 1.409 billion yuan and a turnover rate of 75.88% [7] New Counseling Records - A total of 14 companies received new counseling records from February 2 to February 8, including: - Tianjin Sanying Precision Instrument Co., Ltd. focusing on high-end X-ray non-destructive testing equipment [9] - Tianyi Space Technology Co., Ltd. specializing in SAR satellite constellation operations [10] - Guangdong Shenpeng Technology Co., Ltd. engaged in the development and production of brushless DC electronic water pumps [10] Approval Status - Three companies successfully passed the review process from February 2 to February 8: - Anhui Xinfeng New Energy Technology Co., Ltd. focusing on thermal management components for new energy vehicles [14] - Guangdong Huahui Intelligent Equipment Co., Ltd. specializing in high-end intelligent equipment [14] - Shandong Chunguang Technology Group Co., Ltd. aiming to become a world-class manufacturer of magnetic materials [15] Registration Approval - Two companies received registration approval during the same period: - Wuhu Aiteke Automotive Electronics Co., Ltd. providing automotive electronic solutions [16] - Hangzhou Gaote Electronic Equipment Co., Ltd. focusing on battery management systems for the new energy sector [16] Termination of Review - Wuxi Jiangsong Technology Co., Ltd. withdrew its IPO application during the period, specializing in high-end intelligent equipment for photovoltaic cells [19]

Group 1 - Shenzhen Beixin Life Technology Co., Ltd. focuses on cardiovascular precision intervention solutions, addressing urgent clinical needs and competing with international innovative products [1] - The company has achieved significant milestones, including the first approved FFR system and the first domestically developed 60MHz IVUS system in China, filling gaps in domestic offerings [1] - Beixin Life has established a comprehensive chain for the independent research, production, and commercialization of high-end active interventional devices and consumables, achieving process localization and international quality standards [1] Group 2 - Beixin Life has received multiple recognitions, including being named a national "Little Giant" enterprise and a high-tech enterprise, with an increasing export share of high-end Class III medical devices [2] - The FFR system received EU MDD certification in March 2020, and the IVUS system is expected to receive EU MDR certification in May 2024, showcasing the company's innovation in medical devices [2] - The company has obtained over 20 Class III medical device registrations and more than 80 authorized invention patents, serving over 1,500 hospitals in more than 50 countries [2] Group 3 - Beixin Life was recognized in the "2024 Chuangyebang 100 Future Unicorn" list, highlighting its innovation capabilities and growth prospects in the high-performance medical device sector [3] - The company aims to continue its leadership in intelligent cardiovascular precision intervention solutions, enhancing product quality and services to improve patient health globally [3] - Beixin Life is committed to fostering the global competitiveness of China's high-performance medical device industry [3]